Oliva-Damaso, E.; Oliva-Damaso, N.; Rodriguez-Esparragon, F.; Payan, J.; Baamonde-Laborda, E.; Gonzalez-Cabrera, F.; Santana-Estupiñan, R.; Rodriguez-Perez, J.C.
Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach. Int. J. Mol. Sci. 2019, 20, 3668.
https://doi.org/10.3390/ijms20153668
AMA Style
Oliva-Damaso E, Oliva-Damaso N, Rodriguez-Esparragon F, Payan J, Baamonde-Laborda E, Gonzalez-Cabrera F, Santana-Estupiñan R, Rodriguez-Perez JC.
Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach. International Journal of Molecular Sciences. 2019; 20(15):3668.
https://doi.org/10.3390/ijms20153668
Chicago/Turabian Style
Oliva-Damaso, Elena, Nestor Oliva-Damaso, Francisco Rodriguez-Esparragon, Juan Payan, Eduardo Baamonde-Laborda, Fayna Gonzalez-Cabrera, Raquel Santana-Estupiñan, and Jose Carlos Rodriguez-Perez.
2019. "Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach" International Journal of Molecular Sciences 20, no. 15: 3668.
https://doi.org/10.3390/ijms20153668
APA Style
Oliva-Damaso, E., Oliva-Damaso, N., Rodriguez-Esparragon, F., Payan, J., Baamonde-Laborda, E., Gonzalez-Cabrera, F., Santana-Estupiñan, R., & Rodriguez-Perez, J. C.
(2019). Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach. International Journal of Molecular Sciences, 20(15), 3668.
https://doi.org/10.3390/ijms20153668
